← Back
Data updated: Mar 10, 2026
ORBION PHARMS
NeurologyImmunology
ORBION PHARMS is a generic drug manufacturer focused on Neurology, Immunology. Key products include PANTOPRAZOLE SODIUM.
2007
Since
27
Drugs
-
Trials
425
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ARIPIPRAZOLE 2026-02-18
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 50%
2 drugs
Immunology 50%
0 drugs Phase 3: 2 Phase 2: 2
Pipeline Strength Pro
Loading...
Active (12)
Discontinued (15)
Company Info
- First Approval
- 2007-07-02
- Latest
- 2026-02-03
- Applications
- 29